Studies have shown that immune-related genes (like ABL1, ATF2, CD38, ICOSLG, and many others) were significantly related to patients' OS and that immunohistochemically identified tumor-infiltrating CD4+ and CD8+ T lymphocytes would also help to categorize the low and high risk of unfavorable prognosis [29]. This evidence concerns the gene CD8A and neoplasm.